Quarterly report pursuant to Section 13 or 15(d)

Subsequent Events (Details)

v3.23.3
Subsequent Events (Details) - USD ($)
3 Months Ended
Sep. 18, 2023
Sep. 15, 2023
Aug. 16, 2023
Jul. 13, 2023
Jul. 12, 2023
Jun. 15, 2023
May 12, 2023
Apr. 13, 2023
Mar. 13, 2023
Mar. 31, 2023
Jun. 30, 2023
Dec. 31, 2022
Subsequent Event [Member]                        
Subsequent Event [Line Items]                        
Redemption price (in dollars per share)   $ 10.74                    
Aggregate redemption amount   $ 14,400,000                    
Class A Ordinary Shares [Member]                        
Subsequent Event [Line Items]                        
Number of shares held redeemed (in shares)                 28,119,098      
Redemption price (in dollars per share)                 $ 10.23   $ 10.59 $ 10.15
Aggregate redemption amount                 $ 287,700,000      
Class A Ordinary Shares [Member] | Subsequent Event [Member]                        
Subsequent Event [Line Items]                        
Number of shares held redeemed (in shares)   1,339,804                    
Redemption price (in dollars per share)   $ 10.74                    
Aggregate redemption amount   $ 14,400,000                    
APRINOIA Therapeutics Inc. [Member] | Advance Agreement [Member]                        
Subsequent Event [Line Items]                        
Proceeds from related party advance amount           $ 165,000 $ 165,000 $ 165,000   $ 165,000    
APRINOIA Therapeutics Inc. [Member] | Advance Agreement [Member] | Subsequent Event [Member]                        
Subsequent Event [Line Items]                        
Proceeds from related party advance amount     $ 165,000 $ 165,000 $ 165,000              
Affiliates [Member] | Subsequent Event [Member]                        
Subsequent Event [Line Items]                        
Proceeds from related party advance amount $ 75,000